[Results of clinical testing of "Mydrum", a new mydriatic and cycloplegic agent].
Explore the source record for details and available documents.
SEARCH · PubMed Health
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
For routine mydriasis, many clinicians prefer to utilize a combination of adrenergic and anticholinergic agents. Some clinicians, however, omit the adrenergic agent because of a real or perceived fear of inducing adverse systemic side effects. The agent most often implicated in causing side effects is 10% phenylephrine. Although the 2 1/2% concentration rarely results in adverse systemic side effects when applied topically for pupillary dilation, we undertook this study to determine whether another adrenergic agent, 1% hydroxyamphetamine, which lacks the notoriety of phenylephrine, would be equally effective in producing mydriasis.